Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
A 1163 , 96104
No Surgery
Not intended for use by
Baseline liver enzyme assessment is reasonable for patients with: Pre-existing liver disease or elevated baseline transaminases Metabolic syndrome or clinical features suggesting MASLD Concurrent use of other potentially hepatotoxic medications Obesity (BMI 30 kg/m) with additional metabolic risk factors History of excessive alcohol consumption For patients with abnormal baseline liver enzymes, periodic monitoring every 3-6 months during the first year of therapy allows clinicians to assess treatment response and detect any unexpected changes
/assets/production/practices/8374cadb2253e5496cfee3ef82ab5175a5e6343b/images/2820182.png)
US$ 22.78
US$ 28.14
US$ 22.99
US$ 25.30
US$ 29.47
US$ 25.84
